-
Buy J B Chemicals & Pharmaceuticals, target price Rs 2,225: JM Financial
25 Apr 2025 09:43 GMT
… #47;revenue segments include Pharmaceuticals, Other Operating Revenue, Export … their report to the Drug Techincal Advisory Board (DTAB … the benefits that the medicine provided. It is … introduce Famotidine (alternate to Ranitidine) products under the Rantac …
-
India May Ban Popular Antacid Ranitidine After Years Of Deliberation On Cancer Risks, Expert Panel Files Report
22 Apr 2025 14:54 GMT
… substances.
The US FDA had suggested that some Ranitidine medicines contain a nitrosamine … examine the safety related to Ranitidine drug due to the presence of … people taking ranitidine should consult their healthcare professional for other treatment options …
-
Racial gaps in IBD care ‘largely vanished’ after accounting for income, Medicaid status
21 Apr 2025 15:08 GMT
… travel time to a doctor, availability of a … variability in diagnosis and treatment patterns. This variability appears … Galapagos, Gilead Sciences, Janssen Pharmaceuticals, Merck, Nestle Health Science, … of manufacturers of generic ranitidine and 3M and owns …
-
British drugs giant accused of hiding link between heartburn medicine and cancer
05 Apr 2025 21:53 GMT
… a connection between its heartburn medication Zantac and cancer.
Zantac … the world’s fastest-selling drug.
But in 2019, GSK … consistent or reliable evidence that ranitidine increases the risk of... cancer … the world’s fastest-selling drug
GSK is accused of …
-
GSK DEADLINE ALERT: ROSEN, LEADING TRIAL ATTORNEYS, Encourages GSK plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action – GSK
05 Apr 2025 20:44 GMT
… GSK removed Zantac, a treatment for heartburn and acid … FDA [U.S. Food and Drug Administration], and the EMA [European Medicines … a causal association between ranitidine therapy and the development … were “consistent with other ranitidine data published prior to …
-
UK Faces Severe Risks in Medical Supply Chain, Report Warns
19 Mar 2025 15:06 GMT
… China for the supply of medical countermeasures. "Successive … called for increased transparency in pharmaceutical supply chains. Other healthcare … For example, in 2019, ranitidine was found to contain N … the intact API. The drug was then withdrawn from …
-
ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSK
04 Mar 2025 00:22 GMT
… GSK removed Zantac, a treatment for heartburn and acid … FDA [U.S. Food and Drug Administration], and the EMA [European Medicines … a causal association between ranitidine therapy and the development … were “consistent with other ranitidine data published prior to …
-
Unmet Need for Advanced Chronic Spontaneous Urticaria Treatments Highlighted in Study
19 Feb 2025 02:00 GMT
… to take montelukast, doxepin, ranitidine, or omalizumab.2 For patients … not find relief with these drugs, medication that calms the overactive immune …
“Add-on treatments, treatment switching, and treatment with higher than FDA-approved doses (omalizumab …
-
After $2.2B Zantac settlement, GSK now faces investor lawsuit over the heartburn medication
06 Feb 2025 13:35 GMT
… the drugmaker’s legal issues with the heartburn treatment were … the company, the FDA and the European Medicines Agency concluded independently … are seeking a jury trial and damages against GSK … warned the FDA of a potential carcinogen in ranitidine—which is …
-
GSK targets £40bn in sales as HIV and cancer drug demand helps offset US vaccine upheaval
05 Feb 2025 09:38 GMT
… demand for specialty medicines like HIV treatments Dovato and Cabenuva … US related to the heartburn drug Zantac.
Once the world … one of its ingredients, ranitidine, caused cancer.
GSK struck … would have on the pharmaceutical sector.
Kennedy has proposed …
About
© 1995-2025